Surgical trauma and vein graft failure: Further evidence for a role of ET-1 in graft occlusion

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Dashwood, Michael ^a   Anand, Radhi ^a   Loesch, Andrzej ^b   Souza, Domingos ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell proliferation; Endothelin ETA ETB receptors; Surgical trauma; Vein graft occlusion

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR;

CELL PROLIFERATION; CELL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM INJURY; GRAFT FAILURE; GRAFT OCCLUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SAPHENOUS VEIN GRAFT; SURGICAL INJURY; VEIN DILATATION;

CELL PROLIFERATION; CORONARY ARTERY BYPASS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GRAFT OCCLUSION, VASCULAR; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SAPHENOUS VEIN; TISSUE AND ORGAN HARVESTING; TREATMENT FAILURE;

EID: 11144278726     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166222.50346.c6     Document Type: Conference Paper

References (12)

1. Izzat MB, West RR, Bryan AJ, et al. Coronary artery bypass surgery: current practice in the United Kingdom. Br Heart J. 1994;71:382-385.
2. Souza D. A new no-touch preparation technique. Technical notes. Scand J Thorac Cardiovasc Surg. 1996;30:41-44.
3. Tsui JCS, Souza DSR, Filbey D, et al. Localization of nitric oxide synthase in saphenous vein grafts harvested with a novel 'no-touch' technique: potential role of nitric oxide contribution to improved early graft patency rates. J Vasc Surg. 2002;35:356-362.
4. Dashwood MR, Noertersheuser P, Kirchenagst M, et al. Altered endothelin-1 binding following balloon angioplasty of pig coronary arteries: effect of the ETA receptor antagonist, LU 135252. Cardiovasc Res. 1999;43:445-456.
5. Dashwood MR, Mehta D, Izzat MB, et al. Distribution of endothelin-1 (ET) receptors (ETA and ETB) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts. Atherosclerosis. 1998;137:233-242.
6. Tsui JCS, Souza DSR, Filbey D, et al. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a 'no-touch' technique. Br J Surg. 2001;88:1209-1215.
7. Tsui JCS, Dashwood MR. Recent strategies to reduce vein graft occlusion: a need to limit the effect of vascular damage. Eur J Vasc Endovasc Surg. 2002;23:202-208.
8. Souza DSR, Bomfim V, Skoglund H, et al. High early patency of saphenous vein graft for coronary artery bypass harvested with surrounding tissue. Ann Thorac Surg. 2001;71:797-800.
9. Desmarowitz U, Dashwood M, Giudiceandrea A, et al. Effect of selective receptor antagonism on the development of intimal hyperplasia in cultured human saphenous vein. Proceedings of the Vascular Surgical Society of Great Britain and Ireland Annual General Meeting, Bournemouth, November 1996.
10. Münter K, Hergenröder S, Unger L, et al. Oral treatment with an ETA-receptor antagonist inhibits neointima formation induced by endothelial injury. Pharm Pharmacol Lett. 1996;6:90-92.
11. Wan S, Yim APC, Johnson JL, et al. The endothelin-1A (ETA) receptor antagonist, BSF 302146, is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts. J Thorac Cardiovasc Surg. 2004;127(5):1317-1322.
12. Dashwood MR, Anand R, Loesch A, et al. Improved vein graft patency using a novel no-touch technique is due to preserved nitric oxide synthase. In: Lewis BS, Halon DA, Flugelman MY, Gensini GF, eds. Frontiers in Coronary Artery Disease. Bologna: Monduzzi Editore. 2003:339-342.